MGB Biopharma

United Kingdom
Snodland, England, United Kingdom, G2 2JJ

Company profile

MGB Biopharma company profile

MGB Biopharma Limited is a biopharmaceutical company established to develop a completely new class of anti-infective medicines based upon compounds which are DNA Minor Groove Binders (MGB) The company has an exceptionally experienced team from both pharma and biotech sectors and is dedicating its focus initially to the development of small molecules with specific antibacterial efffects against resistant bacteria By selecting a new class of antibacterial, the company believes the novel mode of action should prove to be very potent against bacteria as these target organisms will lack any inherent resistance, unlike that typically facing new drugs which are the result of modifications from existing classes of drugs used to treat bacterial infection

Business identity

Contact email
[email protected]
Phone number
+44 (014) 122-8623
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2009-01-01, Year

Headquarters

Postal code
G2 2JJ
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
7
Total equity funding
$12.3M
Last funding
Series Unknown / 2019-08-30
Last equity funding
Series Unknown
Investors
7
Lead investors
2
Founders
1
Articles
13

Founders and investors

Founders

Raymond Spencer

Lead investors

ArchangelsInnovate UK

Investors

ArchangelsFund Twenty8Highlands and Islands EnterpriseInnovate UKTRICAPITAL